企業プロフィール · Healthcare

Mayinglong Pharmaceutical Group Co Ltd

600993 · 上海
国 / 地域
China
上場日
2004年4月23日
従業員数
2,544
公式サイト
www.mayinglong.cn
Buffett Score
72/100
優良
時価総額元 97.07億
売上高(TTM)元 39.29億
EBITDA元 7.1億
純利益率15.29%
ROE14.16%
PER (TTM)16.2
予想PER23.42
EPS元 1.39
配当利回り3.15%
52週レンジ元 21.22 – 元 30.18

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。

この銘柄のレポートはお使いの言語でまだありません。